Status:

COMPLETED

Sodium Management in Acute and Chronic Heart Failure

Lead Sponsor:

Ospedale G. F. Ingrassia

Collaborating Sponsors:

University of Palermo

University of Naples

Conditions:

Heart Failure

Eligibility:

All Genders

18+ years

Brief Summary

The study was aimed to verify the effects of Hypertonic saline solution (HSS) and a moderate sodium (Na) restriction plus high furosemide dose in the short term (hospitalization time) and a moderate N...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Decompensated HF due to ischemic or nonischemic cardiomyopathy,
  • \>18 years of age,
  • HF according to Framingham criteria
  • NYHA functional class III
  • EF \<40%,
  • Serum creatinine \<2,5 mg/dL
  • BUN \<60 mg/dL,
  • Exclusion criteria:
  • NYHA class \> III or \< III,
  • Cerebral vascular disease,
  • Dementia,
  • Cancer,
  • Uncompensated diabetes,
  • Severe hepatic disease
  • Patients requiring pacemaker
  • Previous RCT implantation
  • Alcoholic habit

Exclusion

    Key Trial Info

    Start Date :

    September 1 2000

    Trial Type :

    OBSERVATIONAL

    End Date :

    March 1 2010

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT01156337

    Start Date

    September 1 2000

    End Date

    March 1 2010

    Last Update

    November 21 2011

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    GF Ingrassia Hospital

    Palermo, Italy, 90100

    Sodium Management in Acute and Chronic Heart Failure | DecenTrialz